Elimination of methohexitone after long-term, high-dose infusion in patients with critically elevated intracranial pressure

Critical Care Medicine

Volumn 27, Issue 8, 1999, Pages 1570-1576

  Schickendantz, Joachim ^a,b   Funk, Wolfgang ^a   Ittner, Karl Peter ^a   Gruber, Michael ^a   Taeger, Kai ^a   Kees, Frieder ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b Klinik fur Anaesthesiologie   (Germany)

Author keywords

Barbiturates; Brain injuries; Drug kinetics; Electroencephalogram (EEG); Intracranial pressure; Methohexitone; Neurologic examination; Sedatives

Indexed keywords

METHOHEXITAL; THIOPENTAL;

ADOLESCENT; ADULT; ARTICLE; BRAIN INJURY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG MEGADOSE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTRACRANIAL HYPERTENSION; MALE; PHOTOMETRY; PRIORITY JOURNAL; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; ANESTHETICS, INTRAVENOUS; BRAIN INJURIES; CONSCIOUS SEDATION; CRITICAL ILLNESS; DRUG MONITORING; ELECTROENCEPHALOGRAPHY; FEMALE; GLASGOW COMA SCALE; HUMANS; INFUSIONS, INTRAVENOUS; INTRACRANIAL HYPERTENSION; MALE; METABOLIC CLEARANCE RATE; METHOHEXITAL; MIDDLE AGED; TIME FACTORS; TISSUE DISTRIBUTION;

EID: 0032840962     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199908000-00028     Document Type: Article

References (23)

1. 1. Louis PT, Goddard-Finegold J, Fishman MA, et al: Barbiturates and hyperventilation during intracranial hypertension. Crit Care Med 1993; 21:1200-1206
2. 2. Eisenberg HM, Frankowski RF, Contant CF, et al: High-dose barbiturate control of elevated intracranial pressure in patients with severe head injury. J Neurosurg 1988; 69: 15-23
3. 3. Newell DW, Lam AM: Intensive care management and monitoring. In: Anesthetic management of acute head injury. Lam AM (Ed). New York, McGraw-Hill, 1995, p 250-255
4. 4. Pfenninger E, Rindfleisch F: Diagnostik und Therapie des erhöhten intrakraniellen Druckes. Anaesthesiol Intensivmed 1990; 3:76-83
5. 5. Woster PS, LeBlanc KL: Management of elevated intracranial pressure. Clin Pharm 1990; 9:762-772
6. 6. Hanke J, Krieglstein J: Über die Mechanismen der protektiven Wirkung von Methohexital auf den zerebralen Energiestoffwechsel. Arzneim Forsch/Drug Res 1982; 32: 620-625
7. 7. Nordstrom CH: Cerebral blood flow, vasore-activity and oxygen consumption during barbiturate therapy in severe traumatic brain lesions, J Neurosurg 1988; 68:424-431
8. 8. Hung OR, Varvel JR, Shafer SL, et al: Thiopental pharmacodynamics II. Anesthesiology 1992; 77:237-244
9. 9. Turcant A, Delhumeau A, Premel-Cabic A, et al: Thiopental pharmacokinetics under conditions of long-term infusion. Anesthesiology 1985; 63:50-54
10. 10. Bührer M, Maitre PO, Hung OR, et al: Thiopental pharmacodynamics I. Anesthesiology 1992; 7:226-237
11. 11. Taeger K, Murr R, Schmiedeck P, et al: Thiopentalkinetik bei hochdosierter Anwendung. Anaesthesiol Intensivther Notfallmed 1986; 21:237-244
12. 12. Braun SR, Levin AB, Clark KL: Role of corticosteroids in the development of pneumonia in mechanically ventilated head-trauma victims. Crit Care Med 1986; 14:198-201
13. 13. Eberhardt KEW, Thimm BM, Spring A, et al: Dose-dependent rate of nosocomial pulmonary infection in mechanically ventilated patients with brain oedema receiving barbiturate: A prospective case study. Infection 1992; 20:12-18
14. 14. Fröhlich D, Rothe G, Schwall B, et al: Thiopentone and propofol, but not methohexitone nor midazolam, inhibit neutrophil oxidative response to the bacterial peptide FMLP. Eur J Anaesthesial 1996; 13:582-588
15. 15. Björkman S, Gabrielsson J, Quaynor H, et al: Pharmacokinetics of i.v. and rectal methohexitone in children. Br J Anaesth 1987; 59: 1541-1547
16. 16. Hudson RJ, Stanski DR, Durch PG: Pharmacokinetics of methohexital and thiopental in surgical patients. Anesthesiology 1983; 59: 215-219
17. 17. Knorre WA: Pharmakokinetik: Theoretische Grundlagen und Praktische Anwendungen. Berlin, Akademie-Verlag, 1981
18. 18. Heinzel G, Woloszczak P: TopFit 2.0. Stuttgart, Germany, G Fischer-Verlag, 1993
19. 19. Hughes MA, Glass PSA, James R, et al: Context-sensitive half-time in multicompartment pharmacokinetic models for intravenous anesthetic drugs. Anesthesiology 1992; 76:334-341
20. 20. Le Normand Y, de Villepoix C, Finaud M, et al: Pharmacokinetics and haemodynamic effects of prolonged methohexitone infusion. Br J Clin Pharmacol 1988; 26: 589-594
21. 21. Lauven PM, Schwilden H, Stoeckel H: Threshold hypnotic concentration of methohexitone. Eur J Clin Pharmacol 1987; 33: 261-265
22. 22. Redke F, Björkman S, Rosberg B: Pharmacokinetic and clinical experience of 20-h infusions of methohexitone in intensive care patients with postoperative pyrexia. Br J Anaesth 1991; 66:53-59
23. 23. Breimer DD: Pharmacokinetics of methohexitone following intravenous infusion in humans. Br J Anaesth 1976; 48:643-649